These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15884112)

  • 21. Conversion from cyclosporine to mycophenolate mofetil improves expression of A20 in the rat kidney allografts undergoing chronic rejection.
    Teng D; Lu Y; Gao R; Xin Y; Cao G; Li X; Wang L; Wang J; Wang L; Li Y
    Transplant Proc; 2006 Sep; 38(7):2164-7. PubMed ID: 16980032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity.
    Yang CW; Ahn HJ; Kim WY; Li C; Kim HW; Choi BS; Cha JH; Kim YS; Kim J; Bang BK
    Kidney Int; 2002 Jul; 62(1):20-30. PubMed ID: 12081560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The synergistic effect of Tautomycetin on Cyclosporine A-mediated immunosuppression in a rodent islet allograft model.
    Wee YM; Choi MY; Kang CH; Kim YH; Kim JH; Lee SK; Yu SY; Kim SC; Han DJ
    Mol Med; 2010; 16(7-8):298-306. PubMed ID: 20440443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
    Guethoff S; Meiser BM; Groetzner J; Eifert S; Grinninger C; Ueberfuhr P; Reichart B; Hagl C; Kaczmarek I
    Transplantation; 2013 Feb; 95(4):629-34. PubMed ID: 23423270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of mycophenolate mofetil on islet allografting to chemically induced or spontaneously diabetic animals.
    Hao L; Wang Y; Chan SM; Lafferty KJ
    Transplant Proc; 1992 Dec; 24(6):2843-4. PubMed ID: 1465967
    [No Abstract]   [Full Text] [Related]  

  • 26. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids.
    Bunnapradist S; Daswani A; Takemoto SK
    Transplantation; 2003 Jul; 76(1):10-5. PubMed ID: 12865780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of mycophenolate mofetil in the experimental allo-transplantation of hepatocytes in rats with fulminant hepatic failure.
    Kontalexis S; Papalois A; Bibidakis E; Gravvanis A; Lykoudis E; Theodossopoulou E; Dimitroulopoulos D; Sfiniadakis I; Prachalias A; Felekouras E; Dedeilias P; Kontogiorgi M; Papadimitriou L; Papadimitriou I
    Transplant Proc; 2004; 36(6):1739-40. PubMed ID: 15350466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.
    Yang CW; Ahn HJ; Kim WY; Li C; Jung JY; Yoon SA; Kim YS; Cha JH; Kim J; Bang BK
    Transplantation; 2003 Feb; 75(3):309-15. PubMed ID: 12589150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of leflunomide and cyclosporine on concordant xenogeneic islet transplantation in streptozotocin-induced and autoimmune diabetic mice.
    Guo Z; Chong AS; Tian Y; Shen J; Yin D; Mital D; Foster P; Sankary H; McChesney L; Jensik S; Williams JW
    Transplant Proc; 1997 Jun; 29(4):2155. PubMed ID: 9193568
    [No Abstract]   [Full Text] [Related]  

  • 30. Mycophenolate mofetil and sirolimus in hepatocyte transplantation in an experimental model of toxic acute liver failure.
    Loukopoulos I; Sfiniadakis I; Pillai A; Konstantoulakis M; Androulakis G; Bonatsos V; Zografos G; Papalois A
    J Invest Surg; 2014 Aug; 27(4):205-13. PubMed ID: 24564245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
    Thierry A; Le Meur Y; Ecotière L; Abou-Ayache R; Etienne I; Laurent C; Vuiblet V; Colosio C; Bouvier N; Aldigier JC; Rerolle JP; Javaugue V; Gand E; Bridoux F; Essig M; Hurault de Ligny B; Touchard G
    Transpl Int; 2016 Jan; 29(1):23-33. PubMed ID: 26729582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.
    Wu YG; Lin H; Qian H; Zhao M; Qi XM; Wu GZ; Lin ST
    Inflamm Res; 2006 May; 55(5):192-9. PubMed ID: 16830106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trial.
    Hazzan M; Labalette M; Copin MC; Glowacki F; Provôt F; Pruv FR; Noël C
    J Am Soc Nephrol; 2005 Aug; 16(8):2509-16. PubMed ID: 15987748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different effect of cyclosporine A and mycophenolate mofetil on passive Heymann nephritis in the rat.
    Blume C; Heise G; Hess A; Waldner C; Grabensee B; Schroer K; Heering P
    Nephron Exp Nephrol; 2005; 100(2):e104-12. PubMed ID: 15855806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycophenolate mofetil, azathioprine and cyclophosphamide enhanced efficacy combined with cyclosporine in rat cardiac transplantation.
    Ostraat O; Qi Z; Olausson M; Tufveson G; Ekberg H
    Scand J Immunol; 1997 Apr; 45(4):343-8. PubMed ID: 9105419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
    Gonwa T; Johnson C; Ahsan N; Alfrey EJ; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Leonhardt M; Fitzsimmons WE
    Transplantation; 2003 Jun; 75(12):2048-53. PubMed ID: 12829910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclosporine and mycophenolate mofetil 48 hours before renal transplantation enables the use of low cyclosporine doses and achieves better graft function.
    Maamoun H; Soliman A; Zayed B
    Transplant Proc; 2010 Dec; 42(10):4033-6. PubMed ID: 21168619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental efficacy of mycophenolate mofetil implant on high-risk corneal allograft rejection and its biocompatibility in the anterior chamber of rabbits.
    Xin M; Wang T; Shi W; Wu X
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):609-17. PubMed ID: 22846154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maintenance immunosuppression with mycophenolate mofetil and corticosteroids in pediatric kidney transplantation: temporary benefit but not without risk.
    Cransberg K; Cornelissen M; Lilien M; Van Hoeck K; Davin JC; Nauta J
    Transplantation; 2007 Apr; 83(8):1041-7. PubMed ID: 17452893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.